|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Fixed income securities, available for sale, at fair value (amortized cost $77,424 and $133,213) | ||||||||||||||||||||
| Equity securities, at fair value (cost $0 and $5,650) | ||||||||||||||||||||
| Short-term investments, at cost | ||||||||||||||||||||
| Other investments | ||||||||||||||||||||
| Total investments | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accrued investment income | ||||||||||||||||||||
| Premiums receivable (net of allowance of $225 and $225) | ||||||||||||||||||||
| Reinsurance recoverables on amounts paid | ||||||||||||||||||||
| Reinsurance recoverables on amounts unpaid | ||||||||||||||||||||
| Prepaid reinsurance premiums | ||||||||||||||||||||
| Deferred policy acquisition costs | ||||||||||||||||||||
| Deferred tax asset, net | ||||||||||||||||||||
| Goodwill, net | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Right-of-use asset | ||||||||||||||||||||
| Notes receivable | ||||||||||||||||||||
| Credit facility fee, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Claims liabilities | ||||||||||||||||||||
| Unearned premium reserves | ||||||||||||||||||||
| Due to reinsurers | ||||||||||||||||||||
| Premiums payable | ||||||||||||||||||||
| Lease liability | ||||||||||||||||||||
| Due to deconsolidated affiliates | ||||||||||||||||||||
| Notes payable, net | ||||||||||||||||||||
| Other liabilities and accrued expenses | ||||||||||||||||||||
| Liabilities held for sale | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders' Deficit | ||||||||||||||||||||
| Ordinary voting common shares, $0.003 par value, 800,000,001 shares authorized, shares issued: September 30, 2022 - 17,652,839 and December 31, 2021 - 15,052,839; shares outstanding: September 30, 2022 - 17,652,839 and December 31, 2021 - 14,797,334 | ||||||||||||||||||||
| Ordinary Voting Common Shares | ||||||||||||||||||||
| Total ordinary voting common shares, $0.003 par value, 800,000,001 shares authorized, shares issued: September 30, 2022 - 17,652,839 and December 31, 2021 - 15,052,839; shares outstanding: September 30, 2022 - 17,652,839 and December 31, 2021 - 14,797,334 | ||||||||||||||||||||
| Restricted voting common shares, $0.003 par value, 33,333,334 shares authorized, shares issued and outstanding: September 30, 2022 and December 31, 2021 - 0 | ||||||||||||||||||||
| Restricted voting common shares | ||||||||||||||||||||
| Total restricted voting common shares, $0.003 par value, 33,333,334 shares authorized, shares issued and outstanding: September 30, 2022 and December 31, 2021 - 0 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury stock, at cost: 0 and 255,505 shares of ordinary voting common shares at September 30, 2022 and December 31, 2021, respectively | ||||||||||||||||||||
| Retained deficit | ||||||||||||||||||||
| Accumulated other comprehensive income, net of tax | ||||||||||||||||||||
| Total shareholders' deficit | ||||||||||||||||||||
| Total liabilities and shareholders' deficit | ||||||||||||||||||||
Loading...
